Literature DB >> 12709903

New antimicrobial alkaloids from the roots of Polyalthia longifolia var. pendula.

Shaheen Faizi1, Rashid Ali Khan, Soobia Azher, Shakeel Ahmed Khan, Saima Tauseef, Aqeel Ahmad.   

Abstract

Bioassay-guided isolation studies on the root extract of Polyalthia longifolia var. pendula possessing significant antibacterial activity led to the isolation of three new alkaloids pendulamine A (1), pendulamine B (2) and penduline (3) along with stigmasterol 3-O-beta-D-glucoside, allantoin, the known diterpenoid kolavenic acid, and the azafluorene alkaloid isoursuline. The structures of these compounds have been elucidated with the help of spectroscopic studies including 2D NMR experiments. Compounds 1 and 2, which are the only protoberberine alkaloids having a monosubstituted A ring with a hydroxy group at C-3, were found to be the active antibacterial principles of the roots. Their MIC values ranged between 0.02-20 microg against the tested bacteria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709903     DOI: 10.1055/s-2003-38883

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  14 in total

1.  A divergent route to 9, 10-oxygenated tetrahydroprotoberberine and 8-oxoprotoberberine alkaloids: synthesis of (±)-isocorypalmine and oxypalmatine.

Authors:  Satish Gadhiya; Shashikanth Ponnala; Wayne W Harding
Journal:  Tetrahedron       Date:  2015-02-25       Impact factor: 2.457

2.  Development of Synergy-Based Combination of Methanolic Extract of Andrographis paniculata and Berberis aristata Against E. coli and S. aureus.

Authors:  Sageer Abass; Sultan Zahiruddin; Asghar Ali; Mohammad Irfan; Bisma Jan; Qazi Mohd Rizwanul Haq; Syed Akhtar Husain; Sayeed Ahmad
Journal:  Curr Microbiol       Date:  2022-06-15       Impact factor: 2.188

3.  BIAdb: a curated database of benzylisoquinoline alkaloids.

Authors:  Deepak Singla; Arun Sharma; Jasjit Kaur; Bharat Panwar; Gajendra P S Raghava
Journal:  BMC Pharmacol       Date:  2010-03-05

4.  A novel, semi-synthetic diterpenoid 16(R and S)-phenylamino-cleroda-3,13(14), Z-dien-15,16 olide (PGEA-AN) inhibits the growth and cell survival of human neuroblastoma cell line SH-SY5Y by modulating P53 pathway.

Authors:  Syed Saad Hussain; Kinza Rafi; Shaheen Faizi; Zaid Abdul Razzak; Shabana U Simjee
Journal:  Mol Cell Biochem       Date:  2018-04-11       Impact factor: 3.396

5.  Antimicrobial and antioxidant properties of methanol extract, fractions and compounds from the stem bark of Entada abyssinica Stend ex A. Satabie.

Authors:  Gerald N Teke; Paul K Lunga; Hippolyte K Wabo; Jules-Roger Kuiate; Gerard Vilarem; Geraldine Giacinti; Haruhisa Kikuchi; Yoshiteru Oshima
Journal:  BMC Complement Altern Med       Date:  2011-07-19       Impact factor: 3.659

6.  The chemistry, pharmacologic, and therapeutic applications of Polyalthia longifolia.

Authors:  K V Katkar; A C Suthar; V S Chauhan
Journal:  Pharmacogn Rev       Date:  2010-01

7.  Phytochemical screening and in vivo antimalarial activity of extracts from three medicinal plants used in malaria treatment in Nigeria.

Authors:  A E Bankole; A A Adekunle; A A Sowemimo; C E Umebese; O Abiodun; G O Gbotosho
Journal:  Parasitol Res       Date:  2015-09-22       Impact factor: 2.289

8.  Antibacterial and antifungal potentials of the solvents extracts from Eryngium caeruleum, Notholirion thomsonianum and Allium consanguineum.

Authors:  Abdul Sadiq; Sadiq Ahmad; Rahmat Ali; Fawad Ahmad; Sajjad Ahmad; Anwar Zeb; Muhammad Ayaz; Farhat Ullah; Abu Nasar Siddique
Journal:  BMC Complement Altern Med       Date:  2016-11-24       Impact factor: 3.659

9.  Therapeutic Potential of Plants as Anti-microbials for Drug Discovery.

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone
Journal:  Evid Based Complement Alternat Med       Date:  2008-06-24       Impact factor: 2.629

10.  Antibacterial activity of Artemisia nilagirica leaf extracts against clinical and phytopathogenic bacteria.

Authors:  Abdul R Ahameethunisa; Waheeta Hopper
Journal:  BMC Complement Altern Med       Date:  2010-01-29       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.